Study of effects of oral propranolol on amount bleeding during surgery

Evaluation of the effect of propranolol on bleeding from the stapler line during bariatric laparoscopic surgery in morbid obese patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201310108588N17

Enrollment

Registered

2014-05-20

Start date

2013-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid obesity. E66.8

Interventions

Intervention 1: case group receive 40 mg inderal (po) twice a day for one week before surgery. Intervention 2: control group received a 40 mg placebo (po) the same way as case group.

Treatment - Drugs

case group receive 40 mg inderal (po) twice a day for one week before surgery.

control group received a 40 mg placebo (po) the same way as case group.

Eligibility

Sex/Gender

All

Age

16 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: severe obesity that have indication for laparascopic gastric bypass surgery (Patients with BMI over 35 with associated complication or with a BMI over 40). Exclusion Criteria: the patient with inderal contraindication or any reason their operation will be converted to open surgery is excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Frequency of bleeding requiring hemostatsis. Timepoint: During of surgery. Method of measurement: based on surgeon's report.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Alibeigi

Minimally Invasive Surgery Research Center

dralibeigi@yahoo.com+98 21 6655 5447

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026